{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:38:25Z","timestamp":1787017105863,"version":"build-2736575974"},"reference-count":62,"publisher":"BMJ","issue":"9","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Clin Pathol"],"accepted":{"date-parts":[[2020,4,4]]},"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:p>Dilated cardiomyopathy (DCM) represents a common genetic cause of mechanical and\/or electrical dysfunction leading to heart failure (HF) onset for which truncating variants in titin (TTN) gene result in the most frequent mutations. Moreover, myocyte and endothelial cell apoptosis is a key endophenotype underlying cardiac remodelling. Therefore, a deeper knowledge about molecular networks leading to acute injury and apoptosis may reveal novel circulating biomarkers useful to better discriminate HF phenotypes, patients at risk of heart transplant as well as graft reject in order to improve personalised therapy. Remarkably, increased plasma levels of cell-free DNA (cfDNA) may reflect the extent of cellular damage, whereas circulating mitochondrial DNA (mtDNA) may be a promising biomarker of poor prognosis in patients with HF. Furthermore, some panels of circulating miRNAs may improve the stratification of natural history of disease. For example, a combination of miR-558, miR-122* and miR-520d-5p, as well as miR-125a-5p, miR-550a-5p, miR-638 and miR-190a, may aid to discriminate different phenotypes of HF ranging from preserved to reduced ejection fraction. We give update on the most relevant genetic determinants involved in DCM and discuss the putative role of non-invasive biomarkers to overcome current limitations of the reductionist approach in HF management.<\/jats:p>","DOI":"10.1136\/jclinpath-2019-206404","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T17:15:51Z","timestamp":1593710151000},"page":"535-543","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":30,"title":["Epigenetic-sensitive liquid biomarkers and personalised therapy in advanced heart failure: a focus on cell-free DNA and microRNAs"],"prefix":"10.1136","volume":"73","clinical-trial-number":[{"clinical-trial-number":"nct01798992","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0544-5100","authenticated-orcid":false,"given":"Gelsomina","family":"Mansueto","sequence":"first","affiliation":[{"name":"Clinical Department of Internal Medicine and Specialistics, Department of Advanced Medical and Surgical Sciences (DAMSS), University of Campania \"Luigi Vanvitelli\", Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7552-3522","authenticated-orcid":false,"given":"Giuditta","family":"Benincasa","sequence":"additional","affiliation":[{"name":"Department of Advanced Medical and Surgical Sciences (DAMSS), University of Campania \"Luigi Vanvitelli\", Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6383-2176","authenticated-orcid":false,"given":"Nunzia","family":"Della Mura","sequence":"additional","affiliation":[{"name":"IRCCS SDN, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Francesco","family":"Nicoletti","sequence":"additional","affiliation":[{"name":"Multidisciplinary Department of Medical, Surgical and Dental Sciences, Plastic Surgery Unit, University of Campania \"Luigi Vanvitelli\", Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Napoli","sequence":"additional","affiliation":[{"name":"Clinical Department of Internal Medicine and Specialistics, Department of Advanced Medical and Surgical Sciences (DAMSS), University of Campania \"Luigi Vanvitelli\", Naples, Italy"},{"name":"IRCCS SDN, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,7,2]]},"reference":[{"key":"2025121400075966000_73.9.535.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.04.025"},{"key":"2025121400075966000_73.9.535.2","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2009.8"},{"key":"2025121400075966000_73.9.535.3","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1177\/2047487318790822","article-title":"Protective effect of physical activity on mortality in older adults with advanced chronic heart failure: a prospective observational study","volume":"26","author":"Cacciatore","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"2025121400075966000_73.9.535.4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10741-019-09823-z","article-title":"Risk of heart failure progression in patients with reduced ejection fraction: mechanisms and therapeutic options","volume":"25","author":"Gronda","year":"2020","journal-title":"Heart Fail Rev"},{"key":"2025121400075966000_73.9.535.5","doi-asserted-by":"crossref","first-page":"640","DOI":"10.2459\/JCM.0000000000000834","article-title":"Unresolved issues in left ventricular postischemic remodeling and progression to heart failure","volume":"20","author":"Gronda","year":"2019","journal-title":"J Cardiovasc Med"},{"key":"2025121400075966000_73.9.535.6","first-page":"204800401773447","article-title":"Myocardial remodelling and recovery in dilated cardiomyopathy","volume":"6","author":"Tayal","year":"2017","journal-title":"JRSM Cardiovasc Dis"},{"key":"2025121400075966000_73.9.535.7","doi-asserted-by":"publisher","DOI":"10.2217\/fca.11.24"},{"key":"2025121400075966000_73.9.535.8","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/ejhf.1119","article-title":"Transcoronary concentration gradients of circulating microRNAs in heart failure","volume":"20","author":"De Rosa","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2025121400075966000_73.9.535.9","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1161\/ATVBAHA.118.312262","article-title":"Epigenetic inheritance underlying pulmonary arterial hypertension","volume":"39","author":"Napoli","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2025121400075966000_73.9.535.10","article-title":"Differential epigenetic factors in the prediction of cardiovascular risk in diabetic patients","author":"Napoli","year":"2019","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2025121400075966000_73.9.535.11","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2019-206178"},{"key":"2025121400075966000_73.9.535.12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2019.03.008","article-title":"Interplay between genetics and epigenetics in modulating the risk of venous thromboembolism: a new challenge for personalized therapy","volume":"177","author":"Benincasa","year":"2019","journal-title":"Thromb Res"},{"key":"2025121400075966000_73.9.535.13","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/jcp.29064","article-title":"MicroRNA-33 and SIRT1 influence the coronary thrombus burden in hyperglycemic STEMI patients","volume":"235","author":"D'Onofrio","year":"2020","journal-title":"J Cell Physiol"},{"key":"2025121400075966000_73.9.535.14","doi-asserted-by":"crossref","first-page":"539","DOI":"10.5603\/CJ.a2017.0052","article-title":"Heart failure: pilot transcriptomic analysis of cardiac tissue by RNA-sequencing","volume":"24","author":"Schiano","year":"2017","journal-title":"Cardiol J"},{"key":"2025121400075966000_73.9.535.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2015.02.005"},{"key":"2025121400075966000_73.9.535.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.05.027"},{"key":"2025121400075966000_73.9.535.17","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/0971-9784.192617","article-title":"Left ventricular global systolic function assessment by echocardiography","volume":"19","author":"Chengode","year":"2016","journal-title":"Ann Card Anaesth"},{"key":"2025121400075966000_73.9.535.18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.309396"},{"key":"2025121400075966000_73.9.535.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2013.11.010"},{"key":"2025121400075966000_73.9.535.20","doi-asserted-by":"crossref","DOI":"10.5551\/jat.52407","article-title":"Network medicine: a clinical approach for precision medicine and personalized therapy in coronary heart disease","volume":"27","author":"Infante","year":"2020","journal-title":"J Atheroscler Thromb"},{"key":"2025121400075966000_73.9.535.21","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.031110"},{"key":"2025121400075966000_73.9.535.22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00392-016-1033-6","article-title":"Genotype-Phenotype associations in dilated cardiomyopathy: meta-analysis on more than 8000 individuals","volume":"106","author":"Kayvanpour","year":"2017","journal-title":"Clin Res Cardiol"},{"key":"2025121400075966000_73.9.535.23","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.6520","article-title":"Association of titin-truncating genetic variants with life-threatening cardiac arrhythmias in patients with dilated cardiomyopathy and implanted defibrillators","volume":"2","author":"Corden","year":"2019","journal-title":"JAMA Netw Open"},{"key":"2025121400075966000_73.9.535.24","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3719"},{"key":"2025121400075966000_73.9.535.25","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-8032-8_17"},{"key":"2025121400075966000_73.9.535.26","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.116.001603","article-title":"Gene-Based Risk Stratification for Cardiac Disorders in LMNA Mutation Carriers","volume":"10","author":"Nishiuchi","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"key":"2025121400075966000_73.9.535.27","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddv468"},{"key":"2025121400075966000_73.9.535.28","first-page":"S163","article-title":"Modeling the dilated cardiomyopathy with ataxia syndrome (DCMA), a pediatric mitochondrial cardiomyopathy, using cardiomyocytes derived from induced pluripotent stem cells","volume":"33","author":"Rohani","year":"2017","journal-title":"Can J Cardiol"},{"key":"2025121400075966000_73.9.535.29","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2019.306621"},{"key":"2025121400075966000_73.9.535.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.08.066"},{"key":"2025121400075966000_73.9.535.31","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s12265-017-9744-2","article-title":"The dynamics of cardiovascular biomarkers in non-elite marathon runners","volume":"10","author":"Roca","year":"2017","journal-title":"J Cardiovasc Transl Res"},{"key":"2025121400075966000_73.9.535.32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biochi.2019.06.014","article-title":"Increasing evidence of pathogenic role of the mediator (Med) complex in the development of cardiovascular diseases","volume":"165","author":"Napoli","year":"2019","journal-title":"Biochimie"},{"key":"2025121400075966000_73.9.535.33","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fcvm.2019.00020","article-title":"Angiogenic endothelial cell signaling in cardiac hypertrophy and heart failure","volume":"6","author":"Gogiraju","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"2025121400075966000_73.9.535.34","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.410"},{"key":"2025121400075966000_73.9.535.35","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3892\/ijmm.2014.1991","article-title":"A novel Alu-based real-time PCR method for the quantitative detection of plasma circulating cell-free DNA: sensitivity and specificity for the diagnosis of myocardial infarction","volume":"35","author":"Lou","year":"2015","journal-title":"Int J Mol Med"},{"key":"2025121400075966000_73.9.535.36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03961-y"},{"key":"2025121400075966000_73.9.535.37","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-010-0527-8"},{"key":"2025121400075966000_73.9.535.38","doi-asserted-by":"crossref","first-page":"S397","DOI":"10.1016\/j.healun.2017.01.1131","article-title":"Association between LVAD and cardiac allograft injury following heart transplantation as assessed by cell-free DNA","volume":"36","author":"Rodrigo","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"2025121400075966000_73.9.535.39","article-title":"Release of mitochondrial DNA is associated with mortality in severe acute heart failure","author":"Krychtiuk","year":"2019","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2025121400075966000_73.9.535.40","doi-asserted-by":"publisher","DOI":"10.1038\/nrg3863"},{"key":"2025121400075966000_73.9.535.41","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R034991"},{"key":"2025121400075966000_73.9.535.42","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.trre.2017.08.004","article-title":"The epigenetic promise to improve prognosis of heart failure and heart transplantation","volume":"31","author":"Sabia","year":"2017","journal-title":"Transplant Rev"},{"key":"2025121400075966000_73.9.535.43","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfr155"},{"key":"2025121400075966000_73.9.535.44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142237","article-title":"Circulating microRNAs and outcome in patients with acute heart failure","volume":"10","author":"Seronde","year":"2015","journal-title":"PLoS One"},{"key":"2025121400075966000_73.9.535.45","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1159\/000459899","article-title":"Circulating miR-30d predicts survival in patients with acute heart failure","volume":"41","author":"Xiao","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"2025121400075966000_73.9.535.46","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.b12-00578"},{"key":"2025121400075966000_73.9.535.47","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht256"},{"key":"2025121400075966000_73.9.535.48","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ejhf.223","article-title":"Circulating microRNAs in heart failure with reduced and preserved left ventricular ejection fraction","volume":"17","author":"Wong","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2025121400075966000_73.9.535.49","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.244"},{"key":"2025121400075966000_73.9.535.50","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89169","article-title":"Myocardial microRNAs associated with reverse remodeling in human heart failure","volume":"2","author":"Sucharov","year":"2017","journal-title":"JCI Insight"},{"key":"2025121400075966000_73.9.535.51","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1755-5922.2010.00247.x","article-title":"Myocardial reverse remodeling","volume":"30","author":"Hellawell","year":"2012","journal-title":"Cardiovasc Ther"},{"key":"2025121400075966000_73.9.535.52","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.cardfail.2017.04.005","article-title":"Advancing the science of myocardial recovery with mechanical circulatory support: a working group of the National, heart, lung and blood Institute","volume":"23","author":"Drakos","year":"2017","journal-title":"J Card Fail"},{"key":"2025121400075966000_73.9.535.53","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hft088"},{"key":"2025121400075966000_73.9.535.54","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.013220"},{"key":"2025121400075966000_73.9.535.55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2012.08.014"},{"key":"2025121400075966000_73.9.535.56","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.1996.0193"},{"key":"2025121400075966000_73.9.535.57","doi-asserted-by":"publisher","DOI":"10.4049\/immunohorizons.1900026"},{"key":"2025121400075966000_73.9.535.58","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1001\/jamacardio.2018.3546","article-title":"Epigenetic hallmarks of fetal early atherosclerotic lesions in humans","volume":"3","author":"de Nigris","year":"2018","journal-title":"JAMA Cardiol"},{"key":"2025121400075966000_73.9.535.59","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jjcc.2016.10.004","article-title":"Evidence of epigenetic tags in cardiac fibrosis","volume":"69","author":"Grimaldi","year":"2017","journal-title":"J Cardiol"},{"key":"2025121400075966000_73.9.535.60","doi-asserted-by":"crossref","first-page":"107514","DOI":"10.1016\/j.pharmthera.2020.107514","article-title":"Epigenetic-sensitive pathways in personalized therapy of major cardiovascular diseases","volume":"210","author":"Schiano","year":"2020","journal-title":"Pharmacol Ther"},{"key":"2025121400075966000_73.9.535.61","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ahj.2020.03.007","article-title":"Precision medicine in distinct heart failure phenotypes: focus on clinical epigenetics","volume":"224","author":"Napoli","year":"2020","journal-title":"Am Heart J"},{"key":"2025121400075966000_73.9.535.62","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1253\/circj.CJ-19-0879","article-title":"Strengths and opportunities of network medicine in cardiovascular diseases","volume":"84","author":"Benincasa","year":"2020","journal-title":"Circ J"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jclinpath-2019-206404","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T08:08:10Z","timestamp":1765699690000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jclinpath-2019-206404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,2]]},"references-count":62,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,8,19]]},"published-print":{"date-parts":[[2020,9]]}},"alternative-id":["10.1136\/jclinpath-2019-206404"],"URL":"https:\/\/doi.org\/10.1136\/jclinpath-2019-206404","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"value":"0021-9746","type":"print"},{"value":"1472-4146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,2]]}}}